The Hughes Medical Institute was one of America's most renowned nonprofit medical research institutes. When global bioterrorism broke out, under the coordination of the World Health Organization, the Hughes Medical Institute became the research institute where the Angel Team worked to develop a specific drug for the VFV Virus.
Qiu Xiang led several team members toward the conference room.
Qiu Xiang held a report on VFV antibody research, but there was little joy on anyone's face.
Antibodies in patients' serum or bodily fluids had always proven effective in treating viral infections and were also the most commonly used method. However, after researching this for some time, their team discovered that the antibodies in patients' serum were far too weak to eliminate the VFV Virus.
Nor could they find recovered patients. The VFV Virus was too virulent; the antibodies generated by the human immune system simply could not "kill" this virus.
This had left their research into a specific drug at a complete standstill.
After discussion, the team decided to try animal immune serum. They brought in eight animal species for testing and infected them with the virus, but they soon discovered that even serum from immunized cattle had no obvious effect on VFV treatment.
During this period, they ran experiments every day, trying hundreds of possible approaches.
They tested every hypothesis they had discussed and ultimately found that monoclonal antibodies had the greatest chance of success.
To speed up the research, the seventy-two-member team split into eight groups. Four groups searched for other treatments, while the remaining four tested sixteen developed monoclonal antibodies. Qiu Xiang's team was one of those groups.
During testing, all four groups used one thousand times the LD50 to infect laboratory mice.
When the monoclonal antibodies were injected within twenty-four hours of infection, eleven of the